Home » Topics » BioWorld Science

BioWorld Science
RSS

New serine-protein kinase ATM inhibitors described by Medshine Discovery

July 29, 2021

Vonafexor meets primary endpoint in the phase IIa LIVIFY study in patients with NASH

July 29, 2021

FDA authorizes phase II study of autologous adipose-derived mesenchymal stem cells in MS

July 29, 2021

First patients dosed in new studies of Xpovio in melanoma and myelofibrosis

July 29, 2021

Jiangsu Hansoh Pharmaceutical, Shanghai Hansoh Biomedical patent PD-1/PD-L1 inhibitors

July 29, 2021

New RORgammaT agonists identified at Sunshine Lake Pharma

July 29, 2021

Chengdu Baiyu Pharmaceutical presents new tetrahydrocannabinol derivatives

July 29, 2021

DiosCURE enters licensing agreement for single-domain antibodies against SARS-CoV-2

July 28, 2021

Eccogene begins first-in-human study of ECC-0509 for NASH and osteoarthritis pain

July 28, 2021

University of Oxford tests vaccine against plague in phase I

July 28, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...